Relmada Therapeutics Inc. (RLMD)
NASDAQ: RLMDHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
RLMD stock chart
Technical analysisKey statistics
All statistics- Market cap
- $346.68M
- EPS (TTM)
- -$0.91
- Dividend yield
- None
- 52-week range
- 1.80 – 8.00
- Day range
- 3.24 – 3.35
- Volume / Avg
- 1.50M / 1.34M
- Beta
- —
- Shares outstanding
- 106.67M
52-week range
RLMD stock today
Relmada Therapeutics (RLMD) closed at $3.25 on Oct 7, down 0.91% (-$0.03), versus the S&P 500's 0.22% decline. Shares are 59.4% below their 52-week high of $8.00, set on May 6, 2026 and 80.3% above the 52-week low of $1.80, in the middle of the past year's range. RLMD is down 32.7% year to date, underperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has gained 63.3%.
Relmada Therapeutics has posted a net loss over the last twelve months (EPS of -$0.91), so its P/E ratio is not meaningful.
Summary generated from market data by MetaCap's automated system. Methodology
About Relmada Therapeutics
Company profile- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
Relmada Therapeutics peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| ENTAEnanta Pharmaceuticals Inc. | 12.37 | +1.64% | $360.28M | vs RLMD |
| EBSEmergent BioSolutions Inc. | 7.07 | +1.73% | $362.50M | vs RLMD |
| ARCTArcturus Therapeutics Holdings Inc. | 12.77 | -1.81% | $362.82M | vs RLMD |
| GALTGalectin Therapeutics Inc. | 3.62 | -3.72% | $365.08M | vs RLMD |
| IRDOpus Genetics Inc. | 4.41 | +0.68% | $366.89M | vs RLMD |
| TTRXTurn Therapeutics Inc. | 12.10 | +3.95% | $367.45M | vs RLMD |
| CYPHCypherpunk Technologies Inc. | 3.05 | -6.44% | $328.68M | vs RLMD |
| BNTCBenitec Biopharma Inc. | 8.99 | -0.11% | $313.60M | vs RLMD |
Indexes, lists and sector
Relmada Therapeutics stock FAQ
What is Relmada Therapeutics's stock price today?
RLMD last traded at $3.25 as of Oct 7, 4:00 PM EDT, down 0.91% on the day. Prices are delayed at least 15 minutes.
Does Relmada Therapeutics pay a dividend?
No. Relmada Therapeutics does not currently pay a regular cash dividend.
Has RLMD ever split its stock?
Yes. The most recent RLMD stock split was a 1-for-4 split on Sep 30, 2019, one of 2 splits on record.
What is the RLMD 52-week high?
The 52-week high for RLMD is $8.00 and the 52-week low is $1.80. The stock is currently 59.4% below its high.